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ABSTRACT
Objective: Domperidone is a synthetic benzimidazole compound that acts as a dopamine D2 receptor antagonist. The main aim of this study was to 
optimize and evaluate the floating tablets of domperidone that prolongs the gastric residence time using Hibiscus rosa-sinensis mucilage.
Methods: The directly compressible floating tablets of domperidone were formulated using varying amount of hydroxypropyl methylcellulose 
K100 M, carbopol 934P and H. rosa-sinensis mucilage. The effervescent components sodium bicarbonate is used for the generation of CO2 gas. The 
prepared tablets were evaluated for physicochemical parameters and found to be within range, viz., hardness, swelling index, floating capacity, 
thickness, and weight variation. Further, tablets were evaluated for in vitro release characteristics. The concentration of H. rosa-sinensis mucilage with 
a gas-generating agent was optimized to get the sustained release of domperidone.
Result: The % cumulative drug release of all formulation from F1 to F6 was within the range of 81.37% to 98.62% for 18 hrs. The release kinetics of 
all the dosage forms was calculated using zero order, first order, Higuchi, and Korsmeyer–Peppas. It concludes that the release followed zero order 
release, whereas the correlation coefficient (r2 value) was higher for zero order release. The release mechanism follows Higuchi model, Korsmeyer-
Peppas model, and non-Fickian diffusion.
Conclusion: As a result of this study, it may be concluded that the floating tablets using H. rosa-sinensis mucilage in optimized concentrations can 
be used to increase the gastric retention time of the dissolution fluid in the stomach to deliver the drug in a sustained manner. Furthermore, from 
1 month stability data shows no significant change compared to initial result.
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INTRODUCTION
Rapid gastrointestinal transit could result in incomplete drug release 
from the dosage form above the absorption zone leading to diminished 
efficacy of the administered dose. These considerate have led to the 
development of a controlled or sustained delivery system. The main 
purpose for developing these systems was to release the drug slowly 
into the gastrointestinal tract (GIT) and maintain an effective drug 
concentration in the systemic circulation for long time. Gastroretentive 
drug delivery is an approach to prolong gastric retention time, thereby 
targeting site – specific drug release in the upper GIT for local and 
systemic effect. Therefore, different approaches have been proposed 
to retain the dosage form in the stomach. These include bioadhesive 
systems, swelling and expanding systems and floating systems.
Floating drug delivery or hydrodynamically balanced systems have 
a sufficient buoyancy to float over the gastric contents and remain 
buoyant in the stomach without affecting the gastric emptying rate for 
a prolong period [1-4].
Domperidone is a synthetic benzimidazole compound that acts as a 
dopamine D2 receptor antagonist. Its localization outside the blood-brain 
barrier and antiemetic properties other has made it a useful adjunct 
in therapy for Parkinson’s disease. There has been renewed interest in 
antidopaminergic prokinetic agents since the withdrawal of cisapride, a 
5-HT4 agonist, from the market. Domperidone is also used as a prokinetic 
agent for treatment of upper gastrointestinal motility disorders. 
Patients receiving domperidone or other prokinetic agents for diabetic 
gastropathy or gastroparesis should also be managing diet, lifestyle, 
and medications to optimize gastric motility. After oral administration, 
domperidone is rapidly absorbed from the stomach and the upper part 
of the GIT with fewer side effects. It is a weak base with good solubility 
in acidic pH but significantly reduced solubility in alkaline medium [5-7]. 
Such a weak base, formulated as an oral controlled release dosage form is 
exposed to environments of increasing pH with subsequent precipitation 
of poorly soluble free base within the formulation that is no longer 
capable of being released from the formulation.
A majority of the investigations on natural excipients in drug delivery 
systems have centered on proteins and polysaccharides due to their 
ability to produce a wide range of materials and properties according 
to molecular structural alterations. In recent years, plant gums and 
mucilages have evoked tremendous interest due to their diverse 
pharmaceutical applications such as diluents, binders, disintegrants 
in tablets, thickeners in oral liquids, protective colloids in suspensions, 
gelling agents in gels and bases in suppository, thus making them 
attractive substitutes for costly semisynthetic and synthetic excipients. 
India, due to its geographical and environmental positioning, has 
traditionally been a good source for such products among the Asian 
countries. Hibiscus is widely grown as an ornamental plant throughout 
the tropics and subtropics. The plant is available in India in large 
quantities. Its 250 species are widely distributed in tropical and 
subtropical regions of the world and are reported to possess various 
medicinal properties, viz., antitumor, antihypertensive, and antioxidant. 
In this study, an effort was made to extract the mucilage from the leaves 
of Hibiscus rosa-sinensis Linn. and look at the possibility of using this 
mucilage as the floating agents and releasing retardant material in the 
formulation of solid dosage forms [8].
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This study involved the design of gas generating floating tablets of 
domperidone as a model drug. The gas generating system consists 
of hydrophilic matrices prepared with the swellable hydrocolloids 
such as hydroxypropyl methylcellulose (HPMC) K100 M, carbopol 
934P and H. rosa-sinensis mucilage. The effervescent components 
sodium bicarbonate was used for the generation of CO2 gas. When 
the dosage form comes in contact with acidity of gastric contents, 
the CO2 is entrapped in the polymeric network providing the floating 
characteristics to the dosage form [9-11].
MATERIAL AND METHODS
Materials
Domperidone was generously gifted by Ajanta Pharma Ltd. Mumbai. 
H. rosa-sinensis leaves are collected from local area of Nagpur, India. 
Moreover, plant was authenticated at Pharmacognosy Department of 
Department of Pharmaceutical Science of Nagpur University, India, 
and mucilage was extracted in Pharmaceutics Research Lab, HPMC 
K100 M, carbopol 934, sodium bicarbonate, microcrystalline cellulose, 
magnesium stearate and talc were purchased commercially. All solvents 
and reagents used were of analytical grade.
Methods
Extraction of H. rosa-sinensis mucilage
The fresh H. rosa-sinensis Linn. leaves were collected and washed 
with water to remove dirts and debries. Leaves were powdered and 
soaked in water for 5-6 hrs, boiled for 30 minutes and left stand for 
1 hr to allow complete release of mucilage into water. The mucilage 
was extracted using multi-layer muslin cloth bag to remove the marc 
from the solution. Acetone (in the volumes of three times to the volume 
of filtrate) was added to precipitate the mucilage. The mucilage was 
separated, dried, in an oven at 40°C, passed through #80 sieve and 
stored in dessicator at room temperature for further use [9,10].
Purification of H. rosa-sinensis mucilage
The crude mucilage (1%) was obtained after extraction which was 
centrifuged at 10000 rpm, decanted and precipitated in acetone 
following 1:2 mucilaginous solution:acetone ratio, washed with 
isopropyl alcohol with 1:1 volume ratio and finally it was dried [9,10].
Formulation of floating tablet of domperidone by direct 
compression
Floating tablets of domperidone were prepared by direct compression 
method employing sodium bicarbonate as gas generating agent. HPMC 
K100 M and H. rosa-sinensis mucilage, carbopol 934 were used as a 
rate controlling polymers. The concentrations of above ingredients 
were optimized as shown in Table 1. All the ingredients were weighed 
accurately. The drug was mixed with the release rate retarding polymers 
and the mix was blended for 20 minutes to have uniform distribution 
of drug in the formulation. The blend was lubricated with talc and 
magnesium stearate and compressed using 8 station compression 
machines. The tablet weighed for compression was adjusted to 
400 mg [11].
Evaluation of tablets
Precompression parameters and characterization of powders
The flow properties of powders (before compression) were 
characterized in terms of, bulk density, Hausner’s ratio, angle of repose, 
and Carr’s index [4,8].
Physical characterization of tablet
Compressed tablets were then evaluated for shape, diameter and 
thickness, weight variation, disintegration, hardness, friability study. 
Diameter and thickness were measured by vernier caliper. Hardness 
was measured by Monsanto type hardness tester. Friability was 
determined in friabilator (Electrolab EF-2, USP) [5,6].
Assay of tablets
Twenty tablets from each batch were weighed and powdered. Powder 
equivalent to 30 mg of domperidone was accurately weighed and 
transferred into a 100 ml volumetric flask and dissolved in a suitable 
quantity of 0.1 N HCl. The prepared solution was diluted up to 100 ml 
with 0.1 N HCl and sonicated for 60 min. Five milliliters of the resulting 
solution was diluted to 100 ml with 0.1 N HCl to get a concentration 
in the range of 15 μg/ml. A portion of the sample was filtered through 
0.45 μ membrane filter and analyzed by Shimadzu UV-1700 UV/Vis 
double-beam spectrophotometer (Kyoto, Japan) at 284 nm [7,12].
Floating capacity
The in vitro buoyancy was determined by floating lag times. The tablets 
were placed in a 100 ml beaker containing 0.1 N HCl. The time required 
for the tablet to rise to the surface and float was determined as floating 
lag time. The experiments were conducted in triplicate. Total floating 
times were measured during in vitro dissolution [13-15].
Swelling index
The extent of swelling was measured in terms of % of weight gained 
by the tablet. Three tablets from each formulation was weighed and 
kept in Petri dish containing 50 ml of 0.1 N HCL solution. At the end 
of specified time interval, tablets were withdrawn from Petri dish and 
excess buffer was blotted with tissue paper and weighed [13-15].
In vitro dissolution studies
The release rate of domperidone from floating tablets (n=3) was 
determined as per British Pharmacopoeia (BP) using dissolution testing 
apparatus 2 (paddle method). The dissolution test was performed 
using 900 ml of 0.1N HCl, at 37±0.5° and 50 rpm. A sample (5 ml) of the 
solution was withdrawn from the dissolution apparatus hourly for 24 hrs, 
and the samples were replaced with fresh dissolution medium. The 
samples were filtered through 0.45 μ membrane filter and diluted to a 
suitable concentration with 0.1N HCl. Absorbance of these solutions was 
measured at 284 nm using a Shimadzu UV-1700 UV/V is double-beam 
spectrophotometer (Kyoto, Japan). Duration of time the tablets constantly 
float on dissolution medium was noted as total floating time [5-7,12].
Kinetic analysis of in vitro release rate of floating tablets of 
domperidone
The rate and mechanism of release of domperidone from the prepared 
floating tablets were analyzed by fitting the dissolution data into 
following equations:
Zero order kinetics F=k0t
First order kinetics (1-F)=− k1t
To describe the drug release behavior from polymeric systems, 
the dissolution data were also fitted according to the well-known 
exponential Korsmeyer-Peppas equation.
Mt/M∞=Ktn
Table 1: Formulation batches of floating tablet
Ingredients Formulation batches
F1 F2 F3 F4 F5 F6
Domperidone 30 30 30 30 30 30
HPMC K100 M 200 175 175 175 150 100
Hibscus rosa-sinensis
Mucilage
- - 50 50 100 125
Carbopol - 75 50 25 25 25
MCC 110 60 35 60 35 60
Sodium bicarbonate 50 50 50 50 50 50
Magnesium stearate 5 5 5 5 5 5
Talc 5 5 5 5 5 5
Total weight 400 400 400 400 400 400
All quantities are given in mg. MCC: Microcrystalline cellulose, 
HPMC: Hydroxypropyl methylcellulose
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Where, Mt/M∞ is the fraction of drug release at time t and k is the kinetic 
constant, n is the release exponent (indicating the general operating 
release mechanism) [15,16].
For tablets, depending on the aspect ratios values between 0.43 and 
0.5 indicating Fickian (case I) diffusion-mediated release, non-Fickian 
(Anomalous) release, coupled diffusion, and polymer matrix relaxation, 
occurs if 0.5<n<0.89, purely matrix relaxation or erosion-mediated 
release occurs for n=1 (zero order kinetics), and super case II type of 
release for n>0.89.
Statistical analysis
To evaluate contribution of each factor with different levels on 
responses, two-way analysis of variance was performed using SigmaStat 
software (SigmaStat 2.03, SPSS, Chicago, Illinois, USA).
Stability studies
The optimized formulation was kept for short-term stability study. The 
conditions for stability were 30°C±2°C room temperature and relative 
humidity of 65% RH±5% RH. All tablets were suitably packed in group 
of 10 in aluminum foil. At the end of one month, the sealed tablets were 
opened and evaluated for in vitro release and in vitro floating.
RESULTS
Precompression parameters
The domperidone powder mixtures obtained during the precompression 
process were subjected to different parameters and the results were 
represented in Table 2.
Postcompression parameters
Weight variation data of the prepared tablets indicated no significant 
difference in the weight of individual tablet from the average value. 
Hardness of the prepared tablets was observed to be within the range 
of 3.9-4.7 kg/cm2. Thickness of all the tablets was found in the range 
of 3.23- 3.45 mm. Friability of all the tablets was found below 1% was 
shown in Table 3.
The drug content in all the batches of domperidone floating tablets 
was in the range of 98-100% which is within the specified IP limit. This 
ensured the uniformity of the drug content in the tablets represented 
in Table 4.
Swelling index and floating lag time
The swelling index results were depicted in Table 4. It was observed that 
the swelling indexes were increased with increasing H. rosa-sinensis 
gum concentration with carbopol than that of ones containing HPMC 
K100 M alone because of the fact that the H. rosa-sinensis and carbopol 
are more viscous in nature and showed good swelling properties in 
the later periods [8,13]. The formulations had desired floating lag time 
(<80 seconds) and total floating time between 12 and 18 hrs was found 
to be the function of concentration of gum.
In vitro dissolution study
The % cumulative drug releases of all formulations from F1 to F6 were 
within the range of 81.37-98.62% for 18 hrs (Fig. 1). From results of 
in vitro drug release studies, it concludes that F6 had better sustained 
release than the other formulation (Fig. 1). To analyze the domperidone 
release mechanism, the in vitro release data were fitted into various 
release equations and kinetic models (first order, zero order, Higuchi, 
Korsmeyer-Peppas) as indicated by the value of r2, the Higuchi model 
was found to be efficient in describing the diffusion mechanism. To 
explore the release pattern, results of the in vitro release data of all 
formulations were fitted to the Korsmeyer-Peppas equation showed “n” 
value between 0.56 and 0.76 that indicate the drug release occurred via 
non-Fickian diffusion mechanism (Table 5).
Stability study
The results of stability study indicated that there were no significant 
changes in drug content, floating lag time, and floating time (Table 6).
Table 2: Precompression parameters of formulations
Formulation code Angle of repose (θ) Bulk density (g/cc) Tapped density (g/cc) Compressibility index Hausner’s ratio
F1 25.32±0.181 0.68±0.042 0.75±0.026 9.45±0.065 1.01±0.013
F2 25.21±0.248 0.69±0.036 0.74±0.029 9.92±0.028 1.12±0.077
F3 26.90±0.713 0.69±0.026 0.80±0.091 10.34±0.022 1.07±0.017
F4 24.47±0.279 0.70±0.061 0.79±0.036 9.32±0.037 1.09±0.051
F5 26.56±0.423 0.68±0.047 0.79±0.047 13.45±0.048 1.11±0.099
F6 26.91±0.576 0.67±0.036 0.78±0.032 12.62±0.053 1.07±0.031
Mean±SD, n=3, p<0.05. SD: Standard deviation
Table 3: Postcompression parameters‑I of tablets
Formulation code Weight variation Thickness (mm) Hardness (kg/cm2) Friability
F1 399.27±1.181 3.24±0.036 4.4±0.381 0.61±0.351
F2 400.02±3.223 3.38±0.091 3.9±0.296 0.59±0.428
F3 400.16±1.293 3.40±0.073 4.2±0.577 0.67±0.138
F4 400.46±1.173 3.43±0.082 4.7±0.122 0.78±0.149
F5 401.03±2.283 3.45±0.069 4.6±0.091 0.82±0.264
F6 399.36±1.132 3.29±0.089 4.7±0.178 0.62±0.381
mean±SD, n=3, p<0.05. SD: Standard deviation
Table 4: Postcompression parameters‑II of tablets
Formulation code Drug content (%) Floating lag time (s) Swelling index (%) Floating duration (h)
F1 98.23±0.15 70 29.29±0.13 12
F2 99.76±0.21 66 30.09±0.15 13
F3 99.81±0.18 64 33.62±0.05 13
F4 98.48±0.07 64 33.68±0.18 15
F5 98.69±0.19 60 35.96±0.19 15
F6 99.57±0.18 55 38.23±0.12 18
Mean±SD, n=3, p<0.05. SD: Standard deviation
447
Asian J Pharm Clin Res, Vol 10, Issue 3, 2017, 444-448
 Kharwade et al. 
DISCUSSION
From the results of precompression parameter of tablet it was observed 
that the bulk density was found to be between 0.672 and 0.703 g/ml and 
the tapped density ranged between 0.747 and 0.824 g/ml, which make 
them floatable in the gastric fluid. The other micromeritic properties 
such as Carr’s index, Hausner’s ratio revealed no significant differences. 
Angle of repose was to be between 24.35 and 26.91 indicating good 
flow properties. Hardness, friability, weight variation, thickness, 
disintegration time of tablet formulation were within acceptable limits 
and the drug content in all the batches of domperidone ensured the 
uniformity of the drug content in the tablets.
The result of floating lag time demonstrates that the tablets containing 
H. rosa-sinensis gum alone showed longer floating lag time as the 
tablets tend to disintegrate due to the fast release of CO2 gas. This 
may be because of the fact that at lower concentrations, the gum has 
lesser ability to form as gel. This was mainly due to the evolution of 
CO2 entrapped into the matrix of swollen polymer of the matrix and 
well protected by gel formation by the hydrated polymer resulting from 
interaction between the gas generating agent (sodium bicarbonate) 
and dissolution medium (0.1N HCl with pH 1.2) that leads to lowering 
the density and enabling the tablet to float [13,14].
The results revealed that as the amount of H. rosa-sinensis mucilage 
increased, the % swelling increased. This result may be explained 
by the hydrophilic nature H. rosa-sinensis gum which when present 
at optimum concentration with HPMC, rapidly hydrates leading to 
expansion and consequently an ordering of the polymer chains. Tablets 
containing carbopol 934 as copolymer (especially F6) showed higher 
% swelling. It was reported that carbopol swells in simulated gastric 
fluid, pH 1.2. The amount of effervescent mixture incorporated had a 
significant effect on swelling properties of tablet. This may be due to the 
increased reaction of sodium bicarbonate with the dissolution medium 
that increased the release of CO2, and consequently, the number of pores 
and swelling index was increased [16-19].
In vitro dissolution data of formulation (F1 to F6) reported in Fig. 1. The 
overall drug releases from these tablets are governed by burst effect 
followed by gel layer formation, drug diffusion into the gel layer and to 
the dissolution media. These considerations indicate that hydrophilic 
polymers have the potential to sustain the release of drug from tablet. 
Polymer HPMC K100 yielded a faster initial burst effect with desirable 
drug release. The additional use of carbopol and H. rosa-sinensis 
mucilage decreased the release of domperidone from the tablet. Likely 
due to the fact that carbopol and H. rosa-sinensis are cross-linked 
polymers when contacted with water, it would swell and hold water 
inside its microgel network. By increasing the mucilage percentage, 
a viscous gel layer is formed and diffusion of the drug is controlled 
primarily by the gel viscosity. The viscosity of mucilage solutions 
strongly increases with increasing concentration of the mucilage. The 
behavior is attributable to the intermolecular interaction, increasing 
the effective macromolecule dimensions and molecular weight [5,6].
CONCLUSIONS
In this study, gastroretentive floating tablets of domperidone 
were successfully prepared by direct compression method using 
H. rosa-sinensis mucilage. Fabricated tablets showed acceptable weight 
variation, hardness, and uniformity of drug content. The overall results 
explained that the tablets prepared by combination of H. rosa-sinensis 
mucilage, HPMC K100 M, carbopol and gas-generating agent sodium 
bicarbonate, could be more efficient on floating and sustained release 
of domperidone as compared to the tablets prepared using HPMC K100 
M and carbopol only. Thus, proper selection of the ratio of desired drug 
release was achievable.
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